Biblio Discovery — Demo Discovery Service

2 hasil untuk "Stuart L. Cramer"

Menampilkan 1–2 · 0,67 detik · RSS

  1. Artikel Jurnal

    A Phase 1 Study of ABI‐009 (Nab‐sirolimus) in Combination With Temozolomide and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors—A Children's Oncology Group Pediatric Early Phase Clinical Trial Network Study ADVL1514

    Stuart L. Cramer; Alyssa Terry Reddy; Charles Gene Minard dkk.

    Cancer Medicine, Vol. 13 No. 21 · 2024 · Inggris · DOAJ Scopus

    ABSTRACT Background Nab‐sirolimus (ABI‐009, nab‐rapamycin; Aadi Bioscience Inc. [Aadi]) is a human albumin‐bound form of sirolimus nanoparticles, a potent mTOR inhibitor. This phase I trial was conducted to define dose‐limiting toxicities (DLT), maximum tolerated or recommended phase II dose…

  2. Artikel Jurnal

    Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study

    Stuart L. Cramer; Aubrey L. Miller; Joseph G. Pressey dkk.

    Frontiers in Oncology, Vol. 7 · 2018 · Inggris · DOAJ Scopus

    Therapy for rhabdomyosarcoma (RMS) has generally been limited to combinations of conventional cytotoxic agents similar to regimens originally developed in the late 1960s. Recently, identification of molecular alterations through next-generation sequencing of individual tumor specimens has…